Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.55 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.52 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.52 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.52 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | GCGR | P47871 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.50 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.50 |
| ▸ | RAF1 | P04049 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flumizole SCHEMBL15757137 | 1.00 | ESR1 (0.58) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL7089213 | 0.91 | ESR1 (0.50) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL7087514 | 0.88 | TEK (0.53) | ESR1ESR2MAPK11MAPK14ALOX5 | |
| SCHEMBL7089441 | 0.87 | PTGS1 (0.50) | ESR1ESR2NOX1ALOX5 | |
| SCHEMBL11164692 | 0.85 | NOX1 (0.50) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL11087790 | 0.85 | NOX1 (0.50) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL11165161 | 0.85 | NOX1 (0.53) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL11177941 | 0.84 | NOX1 (0.52) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL11170006 | 0.83 | NOX1 (0.57) | ESR1ESR2NOX1MAPK13MAPK12 | |
| SCHEMBL11177151 | 0.82 | NOX1 (0.50) | ESR1ESR2NOX1MAPK13MAPK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3564 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2023212179-A2 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | UNIVERSITY OF MIAMI (US) | 2023-11-02 | — | — | WO | claimed |
| US-20220110979-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC | 2022-04-14 | — | — | US | claimed |
| US-20220088158-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ROIVANT SCIENCES, INC. | 2022-03-24 | — | — | US | claimed |
| EP-3908297-A1 | FIBROBLAST REGENERATIVE CELLS | Figene, LLC (US) | 2021-11-17 | — | — | EP | claimed |
| EP-3279663-B1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020152532-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ENZYVANT THERAPEUTICS GMBH (CH) | 2020-07-30 | — | — | WO | claimed |
| WO-2020146874-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC (US) | 2020-07-16 | — | — | WO | claimed |
| CN-109860675-A | A kind of new-energy automobile fuel cell ion exchange membrane and preparation method thereof | 杨记周 | 2019-06-07 | — | — | CN | claimed |
| EP-0644755-B1 | SURFACE MODIFIED NSAID NANOPARTICLES | NANOSYSTEMS LLC (US) | 1997-03-19 | — | — | EP | claimed |
| EP-0759750-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO, Howard, K. (US) | 1997-03-05 | — | — | EP | claimed |
| US-5591456-A | ADSORPTION ON HYDROXYPROPYL CELLULOSE | NANOSYSTEMS L.L.C. (US) | 1997-01-07 | — | — | US | claimed |
| US-5552160-A | NONSTEROID ANALGESICS FOR REDUCED GASTRIC IRRITATION | NANOSYSTEMS L.L.C. (US) | 1996-09-03 | — | — | US | claimed |
| WO-1996024336-A1 | NSAID NANOPARTICLES | NANOSYSTEMS L.L.C. (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024339-A1 | COMPOSITIONS COMPRISING NANOPARTICLES OF NSAID | NANOSYSTEMS L.L.C. (US) | 1996-08-15 | — | — | WO | claimed |
| US-5518738-A | NONSTEROIDAL ANTIINFLAMMATORY AGENTS, REDUCED GASTRIC IRRITATION | NANOSYSTEM L.L.C. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0644755-A1 | SURFACE MODIFIED NSAID NANOPARTICLES. | EASTMAN KODAK CO (US) | 1995-03-29 | — | — | EP | claimed |
| WO-1993025190-A1 | SURFACE MODIFIED NSAID NANOPARTICLES | EASTMAN KODAK COMPANY (US) | 1993-12-23 | — | — | WO | claimed |